Preoperative empagliflozin and ventricular remodeling after coronary artery bypass grafting in type 2 diabetes: a prespecified analysis of the POST-CABGDM randomized trial.
- DOI
- 10.1186/s13098-026-02232-x
- Published
- 2026 Jul 28
- Container
- Diabetology & metabolic syndrome
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13098-026-02232-x,
title = {Preoperative empagliflozin and ventricular remodeling after coronary artery bypass grafting in type 2 diabetes: a prespecified analysis of the POST-CABGDM randomized trial.},
author = {Popp VO and Pitta FG and de Brito GD and Popp JO and Carvalho LNS and Sampaio LPC and Rached FH and Mioto BM and Bolta PMP and Asdrúbal Vilca Mejía O and Dallan LAO and Filho RK and Abizaid AAC and Serrano CV and Lima EG},
year = {2026},
journal = {Diabetology \& metabolic syndrome},
doi = {10.1186/s13098-026-02232-x},
url = {https://doi.org/10.1186/s13098-026-02232-x}
}RIS
TY - JOUR TI - Preoperative empagliflozin and ventricular remodeling after coronary artery bypass grafting in type 2 diabetes: a prespecified analysis of the POST-CABGDM randomized trial. AU - Popp VO AU - Pitta FG AU - de Brito GD AU - Popp JO AU - Carvalho LNS AU - Sampaio LPC AU - Rached FH AU - Mioto BM AU - Bolta PMP AU - Asdrúbal Vilca Mejía O AU - Dallan LAO AU - Filho RK AU - Abizaid AAC AU - Serrano CV AU - Lima EG PY - 2026 JO - Diabetology & metabolic syndrome DO - 10.1186/s13098-026-02232-x UR - https://doi.org/10.1186/s13098-026-02232-x ER -
APA
VO, P., FG, P., GD, D. B., JO, P., LNS, C., LPC, S., FH, R., BM, M., PMP, B., O, A. V. M., LAO, D., RK, F., AAC, A., CV, S., & EG, L. (2026). Preoperative empagliflozin and ventricular remodeling after coronary artery bypass grafting in type 2 diabetes: a prespecified analysis of the POST-CABGDM randomized trial.. Diabetology & metabolic syndrome. https://doi.org/10.1186/s13098-026-02232-x
Source records
- pubmed · retrieved 2026-11-11T02:01:37.106Z